Global Nasal Spray Market Size, Share, and COVID-19 Impact Analysis, By Product Type (Corticosteroids, salt water solutions, Topical Decongestants, Antihistamine, and Others), By Application (Nasal Allergies, Cold Asthma, and Others), By Age Group (Pediatric and Adults), By Distribution Channel (Drug Stores & Retail Pharmacies, Hospital Pharmacies, and Online Pharmacies), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 – 2033

Industry: Healthcare

RELEASE DATE Mar 2024
REPORT ID SI3910
PAGES 200
REPORT FORMAT PathSoft

Global Nasal Spray Market Insights Forecasts to 2033

  • The Global Nasal Spray Market Size was Valued at USD 10.5 Billion in 2023.
  • The Market Size is Growing at a CAGR of 6.39% from 2023 to 2033.
  • The Worldwide Nasal Spray Market Size  is expected to Reach USD 19.5 Billion by 2033.
  • Europe is expected to Grow the fastest during the forecast period.

 

Global Nasal Spray Market

Get more details on this report -

Request Free Sample PDF

 

The Global Nasal Spray Market Size is expected to reach USD 19.5 Billion by 2033, at a CAGR of 6.39% during the forecast period 2023 to 2033

 

The nasal spray is a device used for drug delivery via the nasal cavity to treat conditions such as allergic rhinitis, cold, asthma, and central nervous system disorders. Nasal sprays are seen as a more efficient way of transporting drugs with potential use in crossing the blood-brain barrier. It is the reliable alternative pathway to the parenteral route of administration with effective drug absorption. The rising prevalence of infections, allergic conditions and other chronic respiratory diseases and nasal disorders drive the global nasal spray market. In addition, efficient and painless drug delivery, easy availability, and better patient convenience are expected to drive the market. Pharmaceutical companies have increased their investments in R&D initiatives to develop new products for the treatment of several diseases like CNS disorder and coronavirus especially during the COVID outbreak. For instance, Glenmark Pharmaceuticals Ltd. launched Fabispray in partnership with SaNOtize, for the treatment of adult patients with COVID-19. However, the potential adverse effects and efficient alternative delivery methods likely to restrain the market. Stringent regulations for the approval of nasal spray manufacturing from regulatory authorities are considered to be more challenging for the nasal spray market.      

 

Report Coverage

This research report categorizes the market for global nasal spray market based on various segments and regions and forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the global nasal spray market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segments of the global nasal spray market.

 

Driving Factors

The increasing prevalence of respiratory disorders surged to increase the market growth. Factors such as tobacco smoking, air pollution, chemicals, dust, and lower respiratory infections during childhood, the increase prevalence of chronic diseases. The tremendous growth of urbanization and industrialization are responsible for rising allergies or infectious diseases, which in turn led to increasing nasal spray market demand. Considering the advantages of nasal spray, increasing the investment in R&D for the development of new and innovative nasal spray products in the pharmaceutical and biotechnology industries. The increasing healthcare expenditure and R&D funding will likely propel the market.      

 

 Restraining Factors

The restriction on nasal spray usage due to its side effects like itching, redness, and swelling in the nose likely to impede the market growth of nasal spray. Stringent regulations from regulatory authorities for the approval may downturn the nasal spray market. In addition, the risk of causing cardiovascular disorder and nasal disorders is impeding the market expansion.   

 

Market Segmentation

The global nasal spray market share is classified into Product Type, Application, Age Group, Distribution Channel.

 

By Product Type Insights

The corticosteroids segment dominates the market with the largest revenue share over the forecast period.

On the basis of product type, the nasal spray market is segmented into corticosteroids, salt water solutions, topical decongestants, antihistamines and others. Among these, the corticosteroids segment is dominating the market with the largest revenue share over the forecast period. The accessibility and affordability of steroid nasal sprays drive the market growth. They are used to treat allergic rhinitis (hay fever), sinusitis, and nasal polyps by improving sinus drainage.

 

By Application Insights

The nasal allergies segment dominates the market with the largest revenue share over the forecast period.

On the basis of application, the nasal spray market is segmented into nasal allergies, cold, asthma and others. Among these, the nasal allergies segment is dominating the market with the largest revenue share over the forecast period. The increasing number of allergic patients increasing the need for allergy treatment, is projected to boost segmental market growth.

 

By Age Group Insights

The adult segment is witnessing significant CAGR growth over the forecast period.

On the basis of age group, the global nasal spray market is segmented into pediatric and adults. Among these, the adult segment is witnessing significant growth over the forecast period. The high prevalence of respiratory diseases in patients over 45 years and a growing number of key market players launching new products for adults escalating the market growth.

 

By Distribution Channel insights

The drug stores & retail segment is witnessing significant CAGR growth over the forecast period.

On the basis of distribution channel, the global nasal spray market is segmented into drug stores & retail pharmacies, hospital pharmacies, and online pharmacies. Among these, the drug stores and retail pharmacies segment is witnessing significant growth over the forecast period. There is a rising nasal spray market at retail pharmacies and drug stores as some of the nasal sprays are purchased over the counter without a prescription.

 

Regional Insights

North America dominates the market with the largest market share over the forecast period.

 

North America

Get more details on this report -

Request Free Sample PDF

 

North America is dominating the market with the largest market share over the forecast period. The increasing prevalence of nasal disorders led to increasing demand for the development of new and innovative nasal sprays. Thus increasing healthcare expenditure and investment in R&D for nasal spray development are responsible for the expansion of the market in the region. In addition, the presence of key market players, and increasing product launches, increasing awareness and demand for nasal spray escalate the nasal spray market in the region.    

 

Europe is expected to grow the fastest during the forecast period. The rising awareness about the nasal spray product among the population is driving the market growth in Europe region. The tremendous increase in urbanization, and industrialization has led to a rise in allergens responsible for allergies and infectious diseases in many people escalating the demand for the nasal spray market. The increasing demand for nasal spray market in the region is expected to drive the market in the coming years.  

 

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the global nasal spray market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market

 

List of Key Market Players

  • GSK plc
  • Viatris Inc.
  • Bayer AG
  • AstraZeneca
  • Johnson & Johnson Services, Inc.
  • The Procter & Gamble Company
  • Cipla, Inc.
  • Emergent Devices
  • Novartis International AG
  • Sanofi-aventis LLC
  • Boehringer Ingelheim
  • Sunovion Pharmaceuticals Inc.
  • Aurena Laboratories
  • GlaxoSmithKline plc
  • Apotex Inc.
  • Others

 

Recent Developments

  • In March 2023, Amneal Pharmaceutocals, Inc. announced the approval of naloxone hydrochloride nasal spray, a generic version of Narcan from the U.S. FDA, to treat known or suspected opioid overdose emergencies.

 

  • In March 2023, Pfizer Inc. has received approval from the USFDA for ZAVZPRET, the first and only calcitonin gene-related peptide (CGRP) receptor antagonist nasal spray for acute migraine treatment in adults.

 

  • In April 2022, SK Bioscience announced its partnership with IAVI for the development of an antiviral nasal spray based on a protein developed by David Baker at the University of Wasington.

 

Market Segment

This study forecasts revenue at global, regional, and country levels from 2020 to 2033. Spherical Insights has segmented the global nasal spray market based on the below-mentioned segments:

 

Nasal spray Market, Product Type Analysis

  • Corticosteroids
  • Salt water solutions
  • Topical decongestants
  • Antihistamines
  • Others

 

Nasal spray Market, Application Analysis

  •  Nasal allergies
  • Cold Asthma
  • Others

 

Nasal spray Market, Age Group Analysis

  • Pediatric
  • Adults

 

Nasal spray Market, Distribution Channel Analysis

  • Drug Stores & Retail Pharmacies
  • Hospital Pharmacies
  • Online Pharmacies

 

Nasal spray Market, Regional Analysis

 

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • Uk
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia Pacific
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Middle East & Africa
    • UAE
    • Saudi Arabia
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

Frequently Asked Questions (FAQ)

  • 1. What is the market size of the Global Nasal spray Market?
    The Global Nasal spray Market is expected to grow from USD 10.5 Billion in 2023 to USD 19.5 Billion by 2033, at a CAGR of 6.39% during the forecast period 2023-2033.
  • 2. Which region is dominating the Global Nasal spray market?
    North America is dominating the Global Nasal spray market.
  • 3. Which are the key companies in the market?
    GSK plc, Viatris Inc., Bayer AG, AstraZeneca, Johnson & Johnson Services, Inc., The Procter & Gamble Company, Cipla, Inc., Emergent Devices, Novartis International AG, Sanofi-aventis LLC, Boehringer Ingelheim, Sunovion Pharmaceuticals Inc., Aurena Laboratories, GlaxoSmithKline plc, Apotex Inc. and Others

Need help to buy this report?

Inquiry Before Buy
We'll use cookies to improve and customize your experience if you continue to browse. Is it OK if we also use cookies to show you personalized ads?
Learn more and manage your cookies
Yes, Accept Cookies